SALIA N CAMPBELL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health JACKSONVILLE, FL NPI 1073294161

General Payments — all program years on this page

$371.48

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $354.66 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $354.6619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $16.821
2024 $354.6619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077962386 Janssen Pharmaceuticals, Inc $7.73 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077962388 Janssen Pharmaceuticals, Inc $20.80 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077962470 Janssen Pharmaceuticals, Inc $23.78 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077962682 Janssen Pharmaceuticals, Inc $21.16 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077962688 Janssen Pharmaceuticals, Inc $28.23 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077962800 Janssen Pharmaceuticals, Inc $6.76 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077963122 Janssen Pharmaceuticals, Inc $7.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077963150 Janssen Pharmaceuticals, Inc $29.26 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077963576 Janssen Pharmaceuticals, Inc $7.51 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077963794 Janssen Pharmaceuticals, Inc $9.28 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106871623 ABBVIE INC. $13.07 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119039213 Otsuka America Pharmaceutical, Inc. $16.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133701980 Gilead Sciences, Inc. $33.75 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144546597 Indivior Inc. $25.05 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151497315 Teva Pharmaceuticals USA, Inc. $21.47 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151497337 Teva Pharmaceuticals USA, Inc. $28.96 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151497379 Teva Pharmaceuticals USA, Inc. $19.26 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151497411 Teva Pharmaceuticals USA, Inc. $20.00 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151497421 Teva Pharmaceuticals USA, Inc. $14.72 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.